Health Canada has expanded the indication for clopidogrel [Plavix; sanofi-aventis, Bristol-Myers Squibb] to include patients with all acute coronary syndromes

Source: Inpharma, Volume 1, Number 1592, 2007-06-16 , pp. 23-23(1)

Keywords: Acute-coronary-syndromes, treatment; Aspirin, therapeutic use; Clopidogrel, therapeutic use; Development-status; Product-approvals

Document Type: Short communication

Links for this article

http://www.ingentaconnect.com/adis/inp/2007/00000001/00001592/art00072
http://openurl.ingenta.com/content?genre=article&issn=1173-8324&volume=1&issue=1592&spage=23&epage=23